strategies used to enhance checkpoint inhibition in hodgkin lymphoma
Published 1 year ago • 32 plays • Length 2:11Download video MP4
Download video MP3
Similar videos
-
1:40
checkpoint inhibitors in hodgkin lymphoma
-
1:51
checkpoint inhibition in the treatment of mpns
-
1:27
the promise of novel checkpoint inhibitors for the treatment of hl
-
0:37
immune checkpoint inhibitors: shaping the future of lymphoma
-
2:07
the role of checkpoint inhibitors in classical hodgkin lymphoma
-
7:15
classic case: hodgkin's lymphoma
-
5:33
cancer immune checkpoint inhibitors
-
4:13
immunotherapy using checkpoint inhibitors (subtitles)
-
1:53
toxicities and new immune checkpoint inhibitors
-
3:30
determining effective combinations of immune checkpoint inhibitors for lymphoma
-
2:39
new findings and challenges in the use of immunotherapy in hodgkin lymphoma
-
1:25
can a avd replace pet-directed strategies for the frontline treatment of hodgkin lymphoma?
-
1:12
optimizing treatment in hodgkin lymphoma
-
3:20
current treatment strategies for newly diagnosed hodgkin lymphoma
-
2:30
strategies to continue improving cure rates in hl and where the field is moving
-
5:46
the use of allogeneic transplantation in the era of checkpoint blockade therapy in hodgkin lymphoma
-
1:58
impact of checkpoint inhibitor-based salvage regimens prior to allosct in r/r chl
-
2:17
the impact of checkpoint inhibitor-based salvage regimens in patients with r/r hl undergoing autosct
-
1:33
combining targeted agents with checkpoint inhibitors in cutaneous t-cell lymphoma
-
1:30
advances in the management of r/r hodgkin lymphoma
-
3:21
nox2: a potential immune checkpoint for inhibition in aml
-
1:10
the sensitization of immune checkpoint inhibitors with subsequent chemotherapy in r/r hl